GENEVA, Aug. 31 -- TRANSCRIPTA BIO, INC. filed a patent application (US2026/016112) for “METHODS AND COMPOSITIONS FOR TREATING 19Q12 AUTISM SPECTRUM DISORDER”. With publication no. WO/2026/178410, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/496
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....